Camp4 Therapeutics Corporation
CAMP
$4.69
-$0.31-6.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -80.40M | -53.40M | -51.78M | -51.77M | -51.79M |
| Total Depreciation and Amortization | 1.64M | 1.69M | 1.69M | 1.68M | 1.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.20M | 7.94M | 6.17M | 6.03M | 5.86M |
| Change in Net Operating Assets | 13.01M | -3.37M | -1.69M | -4.64M | -1.33M |
| Cash from Operations | -29.55M | -47.13M | -45.61M | -48.71M | -45.56M |
| Capital Expenditure | -279.00K | -542.00K | -542.00K | -705.00K | -441.00K |
| Sale of Property, Plant, and Equipment | 36.00K | 36.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -243.00K | -506.00K | -542.00K | -705.00K | -441.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -208.00K | -401.00K | -495.00K | -771.00K | -824.00K |
| Issuance of Common Stock | 57.57M | 109.00M | 76.46M | 76.46M | 76.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 18.53M | 11.77M | -3.37M | -3.98M | -3.98M |
| Cash from Financing | 75.89M | 120.37M | 72.60M | 71.71M | 71.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.09M | 72.73M | 26.45M | 22.30M | 25.66M |